Literature DB >> 8258769

Kinetic analysis of AUC-dependent saturable clearance of liposomes: mathematical description of AUC dependency.

H Harashima1, C Yamane, Y Kume, H Kiwada.   

Abstract

The objective of this study was to examine the AUC dependency of saturable hepatic clearance (CLh) of liposomes and to postulate a mathematical model to describe the characteristics. The AUC dependency of saturable CLh was examined under intravenous rapid administration at various doses. The CLh increased with increasing blood concentration but decreased with the increase of AUC at each dose. In addition, the relationship between AUC and CLh was consistent with that observed in previously reported infusion studies. These experimental data confirm the AUC dependency of saturable CLh of liposomes. A mathematical model was developed for this AUC dependency. The decrease of CLh was described by the uptake amount (X) as follows: CLh = CLm(1-X/Xm), where CLm and Xm represent the maximum uptake clearance and the maximum uptake amount, respectively. The rate equation for uptake was analytically solved as CLh = X/AUC = Xm/AUC(1-exp(CLm/XmAUC)). Uptake clearance can be described by CLm, Xm, and AUC, and so uptake clearance is constant if AUC is constant. These experimental analyses and theoretical considerations show the validity of the AUC-dependent saturable CLh of liposomes.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8258769     DOI: 10.1007/bf01059781

Source DB:  PubMed          Journal:  J Pharmacokinet Biopharm        ISSN: 0090-466X


  14 in total

1.  Non-Michaelis-Menten type hepatic uptake of liposomes in the rat.

Authors:  H Harashima; Y Kume; C Yamane; H Kiwada
Journal:  J Pharm Pharmacol       Date:  1992-09       Impact factor: 3.765

2.  Saturable, non-Michaelis-Menten uptake of liposomes by the reticuloendothelial system.

Authors:  Y Kume; F Maeda; H Harashima; H Kiwada
Journal:  J Pharm Pharmacol       Date:  1991-03       Impact factor: 3.765

3.  Accumulation of indigestible substances reduces fusion competence of macrophage lysosomes.

Authors:  R R Montgomery; P Webster; I Mellman
Journal:  J Immunol       Date:  1991-11-01       Impact factor: 5.422

Review 4.  Physiology and physiopathology of the reticuloendothelial system.

Authors:  T M Saba
Journal:  Arch Intern Med       Date:  1970-12

5.  Effects of dose and vesicle size on the pharmacokinetics of liposomes.

Authors:  Y Sato; H Kiwada; Y Kato
Journal:  Chem Pharm Bull (Tokyo)       Date:  1986-10       Impact factor: 1.645

6.  Distinction between the depletion of opsonins and the saturation of uptake in the dose-dependent hepatic uptake of liposomes.

Authors:  H Harashima; K Sakata; H Kiwada
Journal:  Pharm Res       Date:  1993-04       Impact factor: 4.200

7.  Liposome disposition in vivo. III. Dose and vesicle-size effects.

Authors:  R M Abra; C A Hunt
Journal:  Biochim Biophys Acta       Date:  1981-12-23

8.  A pharmacokinetic analysis program (multi) for microcomputer.

Authors:  K Yamaoka; Y Tanigawara; T Nakagawa; T Uno
Journal:  J Pharmacobiodyn       Date:  1981-11

9.  Contribution of complement system on destabilization of liposomes composed of hydrogenated egg phosphatidylcholine in rat fresh plasma.

Authors:  K Funato; R Yoda; H Kiwada
Journal:  Biochim Biophys Acta       Date:  1992-01-31

10.  Liposome disposition in vivo II: Dose dependency.

Authors:  M E Bosworth; C A Hunt
Journal:  J Pharm Sci       Date:  1982-01       Impact factor: 3.534

View more
  4 in total

1.  Species difference in the disposition of liposomes among mice, rats, and rabbits: allometric relationship and species dependent hepatic uptake mechanism.

Authors:  H Harashima; S Komatsu; S Kojima; C Yanagi; Y Morioka; M Naito; H Kiwada
Journal:  Pharm Res       Date:  1996-07       Impact factor: 4.200

2.  Improved intratumoral delivery of PEG-coated siRNA-lipoplexes by combination with metronomic S-1 dosing in a murine solid tumor model.

Authors:  Tatsuaki Tagami; Amr S Abu Lila; Mariko Matsunaga; Naoto Moriyoshi; Hiroyuki Nakamura; Kazuya Nakamura; Takuya Suzuki; Yusuke Doi; Tatsuhiro Ishida; Hiroshi Kiwada
Journal:  Drug Deliv Transl Res       Date:  2012-04       Impact factor: 4.617

3.  A double-modulation strategy in cancer treatment with a chemotherapeutic agent and siRNA.

Authors:  Kazuya Nakamura; Amr S Abu Lila; Mariko Matsunaga; Yusuke Doi; Tatsuhiro Ishida; Hiroshi Kiwada
Journal:  Mol Ther       Date:  2011-08-30       Impact factor: 11.454

4.  Pharmacokinetic profile of ABELCET (amphotericin B lipid complex injection): combined experience from phase I and phase II studies.

Authors:  A Adedoyin; J F Bernardo; C E Swenson; L E Bolsack; G Horwith; S DeWit; E Kelly; J Klasterksy; J P Sculier; D DeValeriola; E Anaissie; G Lopez-Berestein; A Llanos-Cuentas; A Boyle; R A Branch
Journal:  Antimicrob Agents Chemother       Date:  1997-10       Impact factor: 5.191

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.